Next-Generation Sequencing for Vaccine Research

Next-generation sequencing (NGS) revolutionizes vaccine research by providing an in-depth understanding of the genetic makeup of pathogens. NGS enables the sequencing of entire genomes of viruses or bacteria, allowing researchers to identify critical regions and potential vaccine targets. This technology has accelerated the development of vaccines, particularly in response to emerging infectious diseases like COVID-19, where speed was essential. By identifying genetic variations and mutations in viruses, NGS helps in monitoring the evolution of pathogens, which is crucial for vaccine effectiveness and updating vaccines as needed. Furthermore, NGS allows for the rapid screening of various strains, optimizing vaccine formulations. The ability to analyze vast amounts of genetic data also supports the development of personalized vaccines, targeting specific populations or individuals based on genetic factors.

Related Sessions